INE03Q201024
INE03Q201024
ALIVUS LIFE SCIENCES LTD
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2026 | 2025 | Change % |
|---|---|---|---|
| Total Revenue | 25.041.940.000 | 23.398.350.000 | 7.0% |
| Cost of Revenue | 11.161.570.000 | 11.184.060.000 | 0.2% |
| Gross Profit | 13.880.370.000 | 12.214.290.000 | 13.6% |
| 6.655.700.000 | 5.976.330.000 | 11.4% | |
| Operating Income | 7.224.670.000 | 6.237.960.000 | 15.8% |
| Pretax Income | 7.513.090.000 | 6.541.310.000 | 14.9% |
| Net Income Common Stockholders | 5.644.830.000 | 4.856.270.000 | 16.2% |
| -- | -- | -- | |
| -- | -- | -- |